In October 2024, the International Aluminium Institute (IAI) and Tsinghua University launched "PharmaTrack," a real-time carbon footprint monitoring platform for pharmaceutical aluminum foil. Covering 11 lifecycle stages from bauxite mining to recycling, the blockchain-based system traces emissions to specific mines and energy sources. Pilot data shows green hydropower-produced foil emits only 1.2kg CO₂/kg, an 89% reduction from coal-based methods.


The European Medicines Agency (EMA) mandates carbon footprint reporting for all EU drug packaging by 2025. Six of the global top 10 pharma companies, including Novartis, have adopted "PharmaTrack," achieving 62% emission cuts and €8 million annual carbon credit savings.

‌
BloombergNEF forecasts global low-carbon foil demand to surge 12-fold by 2030. China's Yunnan and Sichuan regions, rich in hydropower, are poised to become key suppliers. A domestic leader announced a ¥5 billion "Zero-Carbon Foil Industrial Park" in Qinghai, integrating solar storage and hydrogen logistics for 500,000-ton annual capacity.